Parametrica Management Ltd Buys New Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Parametrica Management Ltd bought a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the fourth quarter, Holdings Channel reports. The institutional investor bought 7,500 shares of the financial services provider’s stock, valued at approximately $1,019,000. iShares Biotechnology ETF accounts for approximately 1.7% of Parametrica Management Ltd’s portfolio, making the stock its 18th largest holding.

Other large investors have also modified their holdings of the company. Glass Jacobson Investment Advisors llc grew its position in iShares Biotechnology ETF by 150.6% in the third quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 122 shares during the period. Values First Advisors Inc. bought a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth $43,000. Horizon Bancorp Inc. IN bought a new stake in shares of iShares Biotechnology ETF during the third quarter worth $44,000. Tennessee Valley Asset Management Partners bought a new position in iShares Biotechnology ETF in the fourth quarter valued at about $44,000. Finally, Column Capital Advisors LLC bought a new position in iShares Biotechnology ETF in the third quarter valued at about $49,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Up 0.7 %

NASDAQ:IBB traded up $0.82 during mid-day trading on Friday, hitting $126.49. The company had a trading volume of 833,050 shares, compared to its average volume of 1,534,186. iShares Biotechnology ETF has a fifty-two week low of $111.83 and a fifty-two week high of $141.16. The business’s fifty day moving average is $134.45 and its two-hundred day moving average is $129.71.

iShares Biotechnology ETF Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were issued a dividend of $0.126 per share. The ex-dividend date was Thursday, March 21st. This represents a $0.50 annualized dividend and a yield of 0.40%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.